X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with SHASUN PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES SHASUN PHARMA JUBILANT LIFE SCIENCES/
SHASUN PHARMA
 
P/E (TTM) x 26.3 123.9 21.2% View Chart
P/BV x 5.4 8.5 63.3% View Chart
Dividend Yield % 0.3 0.2 144.3%  

Financials

 JUBILANT LIFE SCIENCES   SHASUN PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
SHASUN PHARMA
Mar-14
JUBILANT LIFE SCIENCES/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs18794 198.3%   
Low Rs6546 142.8%   
Sales per share (Unadj.) Rs364.3214.2 170.1%  
Earnings per share (Unadj.) Rs6.85.3 128.3%  
Cash flow per share (Unadj.) Rs24.515.8 154.9%  
Dividends per share (Unadj.) Rs3.001.00 300.0%  
Dividend yield (eoy) %2.41.4 166.5%  
Book value per share (Unadj.) Rs164.953.3 309.1%  
Shares outstanding (eoy) m159.2856.62 281.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.3 105.9%   
Avg P/E ratio x18.413.1 140.4%  
P/CF ratio (eoy) x5.14.4 116.4%  
Price / Book Value ratio x0.81.3 58.3%  
Dividend payout %43.818.7 233.8%   
Avg Mkt Cap Rs m20,0613,958 506.9%   
No. of employees `0006.2NA-   
Total wages/salary Rs m11,0522,164 510.8%   
Avg. sales/employee Rs Th9,383.0NM-  
Avg. wages/employee Rs Th1,786.9NM-  
Avg. net profit/employee Rs Th176.3NM-  
INCOME DATA
Net Sales Rs m58,03412,127 478.6%  
Other income Rs m191229 83.1%   
Total revenues Rs m58,22412,356 471.2%   
Gross profit Rs m5,7861,009 573.4%  
Depreciation Rs m2,812594 473.7%   
Interest Rs m3,237415 779.9%   
Profit before tax Rs m-72230 -31.4%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m696-73 -957.6%   
Profit after tax Rs m1,090302 360.9%  
Gross profit margin %10.08.3 119.8%  
Effective tax rate %-965.9-31.7 3,050.9%   
Net profit margin %1.92.5 75.4%  
BALANCE SHEET DATA
Current assets Rs m29,2806,884 425.3%   
Current liabilities Rs m38,9128,456 460.2%   
Net working cap to sales %-16.6-13.0 128.1%  
Current ratio x0.80.8 92.4%  
Inventory Days Days8462 136.9%  
Debtors Days Days51108 47.1%  
Net fixed assets Rs m55,7124,970 1,120.9%   
Share capital Rs m155113 136.4%   
"Free" reserves Rs m20,9682,875 729.3%   
Net worth Rs m26,2653,020 869.6%   
Long term debt Rs m17,1691,817 944.7%   
Total assets Rs m88,60613,347 663.9%  
Interest coverage x1.01.6 62.9%   
Debt to equity ratio x0.70.6 108.6%  
Sales to assets ratio x0.70.9 72.1%   
Return on assets %4.95.4 90.9%  
Return on equity %4.210.0 41.5%  
Return on capital %11.613.3 86.8%  
Exports to sales %37.846.4 81.5%   
Imports to sales %16.514.2 115.7%   
Exports (fob) Rs m21,9335,622 390.2%   
Imports (cif) Rs m9,5671,728 553.8%   
Fx inflow Rs m22,0045,843 376.6%   
Fx outflow Rs m11,7492,173 540.6%   
Net fx Rs m10,2553,669 279.5%   
CASH FLOW
From Operations Rs m8,026398 2,018.6%  
From Investments Rs m-1,744-1,635 106.7%  
From Financial Activity Rs m-4,4471,309 -339.9%  
Net Cashflow Rs m1,83471 2,576.5%  

Share Holding

Indian Promoters % 45.6 39.2 116.3%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 3.6 241.7%  
FIIs % 21.2 17.6 120.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 39.6 53.3%  
Shareholders   23,815 20,750 114.8%  
Pledged promoter(s) holding % 15.9 12.3 129.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   BIOCON LTD  CADILA HEALTHCARE  SUVEN LIFE  PLETHICO PHARMA  WOCKHARDT LTD.  

Compare JUBILANT LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Feb 23, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - PANACEA BIOTECH COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS